News

An independent analysis conducted by Public Health England (PHE) in the UK demonstrates that the Pfizer-BioNTech COVID-19 vaccine BNT162b2 provides protection against infection and asymptomatic disease after the first dose.

Diabetes is a permanent condition that requires lifetime care, and the incidence is rising. To help manage it, an artificial pancreas system can be utilized which has been upgraded with an AI algorithm. The system automatically measures blood sugar levels to infuse the appropriate amount of insulin into the blood.

Findings from a study published in Nature Communications reveal how cancer cells escape death by lymphocytes through the disruption of interferon-gamma signaling.

Scientists have identified a compound that eliminates the ongoing degeneration of upper motor neurons that become diseased and are a key contributor to amyotrophic lateral sclerosis (ALS).

Glioblastoma multiforme is a common and aggressive form of primary brain tumor that is particularly hard to treat. However, researchers now report a new glioma-targeted nano-therapeutic that will only address tumor cells offering increased effectiveness and reduced side effects.

Researchers from the University of Barcelona have uncovered a specific type of ribonucleic acid (RNA) as a potential therapeutic target for the treatment of Huntington's disease.

A new study suggests that a hormone known to prevent weight gain and normalize metabolism can also help maintain healthy muscles in mice. The findings present new possibilities for treating muscle-wasting conditions associated with age, obesity or cancer.

Research suggests that groups of neurons activated during prior learning continue to form memories in the brain while a person sleeps.

Congenital retinal dystrophies are caused by defects in specific genes. Up until recently, there was no way to treat these conditions. However, the development of dedicated gene-delivery vehicles based on harmless viruses could be of clinical importance.

Propranolol, a drug that is efficacious against infantile haemangiomas (resembling birthmarks), can also be used to treat cerebral cavernous malformations, a condition characterised by misshapen blood vessels in the brain and elsewhere, finds a new study.